Home › Anemia falciforme › New York › New York City
Studi clinici su Anemia falciforme a New York City, NY
13 studi su Anemia falciforme cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
In reclutamentoFase 1
- Mount Sinai Hospital, New York
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
In reclutamentoFase 3
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
In reclutamentoFase 2/3
- Icahn School of Medicine at Mount Sinai, New York
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
In reclutamentoStudio osservazionale
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
In reclutamentoFase 2
- Mount Sinai Medical Center, New York
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
In reclutamentoFase 1/2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
In reclutamentoFase 1
- Columbia University Irving Medical Center, New York
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
In reclutamentoStudio osservazionale
- Columbia Presbytarian (NT-DMT), New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
In reclutamentoFase 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
In reclutamentoFase 2
- Columbia University, New York
A Long-term Follow-up Study in Patients Who Received BEAM-101
In reclutamentoStudio osservazionale
- Columbia University Irving Medical Center, New York
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
In reclutamento
- Weil Cornell Medical College, New York
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
In reclutamentoFase 2
- Mount Sinai Hospital, New York
Studi su Anemia falciforme in altre città
- Atlanta, GA22 studi
- Washington, DC20 studi
- Chicago, IL18 studi
- Memphis, TN18 studi
- Philadelphia, PA15 studi
- Birmingham, AL14 studi
- St. Louis, MO12 studi
- Boston, MA10 studi
- Durham, NC10 studi
- Houston, TX10 studi
- Cincinnati, OH10 studi
- Greenville, NC9 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.